Please use this identifier to cite or link to this item:
Title: Prophylactic Therapy for Hereditary Angioedema
Authors: Longhurst, Hilary;Zinser, Emily
Year: 2017
Publisher: Elsevier Inc
Abstract: Long-term prophylaxis is needed in many patients with hereditary angioedema and poses many challenges. Attenuated androgens are effective in many but are limited by side effect profiles. There is less evidence for efficacy of tranexamic acid and progestagens; however, the small side effect profile makes tranexamic acid an option for prophylaxis in children and progestagens an option for women. C1 inhibitor is beneficial, but at present requires intravenous delivery and may need dose titration for maximum efficacy. Short-term prophylaxis should be considered for all procedures. New therapies are promising in overcoming many problems encountered with current options for long-term prophylaxis.
volume: Volume 37
issue: Issue 3
month: August
Appears in Collections:Immunology and Allergy Clinics of North America 2017

Files in This Item:
File Description SizeFormat 
2017 IACNA Volume 37 Issue 3 August (7).pdf256.4 kBAdobe PDFThumbnail
Download    Request a copy

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.